NCT03937063

Brief Summary

The study shall mainly help to better evaluate the performance the APDS device and secondly it may help to assess the potential of the future alpha version of the device to be a useful and effective for the detection of colon Polyps.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 22, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 1, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2020

Completed
Last Updated

November 16, 2020

Status Verified

March 1, 2020

Enrollment Period

11 months

First QC Date

May 1, 2019

Last Update Submit

November 13, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Recorded colonoscopy video which was verified by visual inspection to have sufficient high quality.

    Each recorded video is visually inspected immediately at the end of the procedure by an experienced team member who rates it with a number between 1 (low quality) to 10 (high quality). Only videos with rate above 7 are considered as having sufficient high quality.

    Half an hour from the end of the procedure at which the video was recorded

  • De-Identified procedure report which was visually inspected to verify that it includes all the needed details about the polyps that were detected during the procedure.

    Each de-Identified procedure report is visually inspected immediately at the end of the procedure by an experienced team member who gives it binary score (0 or 1), 1 if it includes all the needed details about the polyps that were detected during the procedure, and 0 if does not include all the needed details about the polyps that were detected during the procedure.

    Half an hour from the end of the procedure for which the procedure report was filled-in

Interventions

To evaluate, in objective way, the usability of the future alpha version of the APDS device by testing the sensitivity and specificity of its results achieved from running it on the collected recorded videos of Colonoscopy screening tests of the general population.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects shall be recruited by the investigator from within the investigator's patient population of colonoscopy. In this study one site will participate and enroll not less than 200 patients and up to 300 subjects according to the inclusion/exclusion criteria. Each subject (not less than 200 patients and up to 300 subjects) included will pass one regular colonoscopy screening test which will be recorded in the way which is described above. Enrolled subjects that did not complete the full course of the study will be replaced

You may qualify if:

  • Subjects must meet all the - criteria related to regular colonoscopy according to the standard of care at the Gastroenterology Department of the selected center, \_In addition the following - criteria have to be met to be eligible for the study:
  • Able to read, understand and provide written Informed Consent;
  • Females or males - older than 18 years old

You may not qualify if:

  • Bleeding disorder or unacceptable risk of bleeding
  • Terminal illness or life threatening malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erlanger Health System

Chattanooga, Tennessee, 37403, United States

Location

MeSH Terms

Conditions

Colonic Polyps

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2019

First Posted

May 3, 2019

Study Start

March 22, 2019

Primary Completion

February 12, 2020

Study Completion

February 12, 2020

Last Updated

November 16, 2020

Record last verified: 2020-03

Locations